Scissortail Wealth Management LLC Purchases New Stake in Encompass Health Co. (NYSE:EHC)

Scissortail Wealth Management LLC acquired a new stake in shares of Encompass Health Co. (NYSE:EHC) during the fourth quarter, Holdings Channel.com reports. The fund acquired 15,462 shares of the company’s stock, valued at approximately $1,107,000.

A number of other hedge funds have also made changes to their positions in EHC. Vanguard Group Inc. lifted its stake in Encompass Health by 1.2% during the third quarter. Vanguard Group Inc. now owns 9,653,180 shares of the company’s stock valued at $436,613,000 after buying an additional 111,745 shares in the last quarter. William Blair Investment Management LLC raised its stake in Encompass Health by 6.4% during the third quarter. William Blair Investment Management LLC now owns 5,676,379 shares of the company’s stock worth $381,226,000 after acquiring an additional 342,512 shares in the last quarter. Invesco Ltd. increased its stake in shares of Encompass Health by 22.3% in the third quarter. Invesco Ltd. now owns 3,974,306 shares of the company’s stock valued at $266,914,000 after buying an additional 724,544 shares in the last quarter. JPMorgan Chase & Co. increased its position in Encompass Health by 4.4% in the first quarter. JPMorgan Chase & Co. now owns 3,144,147 shares of the company’s stock worth $170,098,000 after purchasing an additional 133,885 shares during the period. Finally, Baupost Group LLC MA boosted its holdings in Encompass Health by 318.9% during the first quarter. Baupost Group LLC MA now owns 3,000,000 shares of the company’s stock worth $213,330,000 after buying an additional 2,283,900 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Down 0.9 %

EHC stock traded down $0.75 on Tuesday, reaching $79.98. 721,965 shares of the company traded hands, compared to its average volume of 651,841. Encompass Health Co. has a one year low of $57.55 and a one year high of $83.73. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.28 and a quick ratio of 1.28. The company has a market cap of $8.01 billion, a P/E ratio of 23.05, a price-to-earnings-growth ratio of 1.49 and a beta of 0.94. The firm has a fifty day simple moving average of $77.01 and a 200-day simple moving average of $70.09.

Encompass Health (NYSE:EHC) last issued its earnings results on Wednesday, February 7th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.83 by $0.12. The business had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. Research analysts anticipate that Encompass Health Co. will post 3.96 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were given a dividend of $0.15 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $0.60 annualized dividend and a yield of 0.75%. Encompass Health’s dividend payout ratio (DPR) is presently 17.29%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on EHC shares. Royal Bank of Canada reissued an “outperform” rating and set a $83.00 target price on shares of Encompass Health in a report on Friday, February 9th. Stephens restated an “overweight” rating and set a $85.00 price objective on shares of Encompass Health in a research report on Tuesday, January 16th. Truist Financial upped their target price on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a report on Friday, February 9th. Mizuho increased their price target on Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, February 9th. Finally, Barclays raised their target price on Encompass Health from $95.00 to $101.00 and gave the stock an “overweight” rating in a research note on Thursday, March 28th. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $83.22.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.